These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 35036028)
1. Correlation between Reactogenicity and Immunogenicity after the ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccination. Lim SY; Kim JY; Park S; Kwon JS; Park JY; Cha HH; Suh MH; Lee HJ; Lim JS; Bae S; Jung J; Lee N; Kim K; Shum D; Jee Y; Kim SH Immune Netw; 2021 Dec; 21(6):e41. PubMed ID: 35036028 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Antibody and T Cell Responses Induced by Single Doses of ChAdOx1 nCoV-19 and BNT162b2 Vaccines. Kim JY; Bae S; Park S; Kwon JS; Lim SY; Park JY; Cha HH; Seo MH; Lee HJ; Lee N; Heo J; Shum D; Jee Y; Kim SH Immune Netw; 2021 Aug; 21(4):e29. PubMed ID: 34522442 [TBL] [Abstract][Full Text] [Related]
3. Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity. Bae S; Ko JH; Choi JY; Park WJ; Lim SY; Ahn JY; Song KH; Lee KH; Song YG; Chan Kim Y; Park YS; Choi WS; Jeong HW; Kim SW; Kwon KT; Kang ES; Kim AR; Jang S; Kim B; Kim SS; Jang HC; Choi JY; Kim SH; Peck KR Clin Microbiol Infect; 2022 Oct; 28(10):1390.e1-1390.e7. PubMed ID: 35598855 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Antibody Response Elicited by ChAdOx1 and BNT162b2 COVID-19 Vaccine. Kang YM; Minn D; Lim J; Lee KD; Jo DH; Choe KW; Kim MJ; Kim JM; Kim KN J Korean Med Sci; 2021 Nov; 36(46):e311. PubMed ID: 34845875 [TBL] [Abstract][Full Text] [Related]
5. Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers. Benning L; Töllner M; Hidmark A; Schaier M; Nusshag C; Kälble F; Reichel P; Buylaert M; Grenz J; Ponath G; Klein K; Zeier M; Süsal C; Schnitzler P; Morath C; Speer C Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34451982 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccine type-dependent differences in immunogenicity and inflammatory response: BNT162b2 and ChAdOx1 nCoV-19. Heo JY; Seo YB; Kim EJ; Lee J; Kim YR; Yoon JG; Noh JY; Cheong HJ; Kim WJ; Yoon SY; Choi JY; Lee YJ; Lee HW; Kim SS; Kim B; Song JY Front Immunol; 2022; 13():975363. PubMed ID: 36119092 [TBL] [Abstract][Full Text] [Related]
8. Reactogenicity and persistence of IgG antibodies against SARS-CoV-2 among recipients of ChAdOx1 nCoV-19 vaccine: A single center experience from Sri Lanka. Govindapala D; Dhanaratna D; Senarath U; Lamabadusuriya D; Senaratne T; Wijenayake W; Wijewardena D; Nakkawita D; Kawyangana P; Kulasekara U; Silva AD; Fernando N Int J Health Sci (Qassim); 2023; 17(1):36-43. PubMed ID: 36704495 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and efficacy of heterologous ChAdOx1-BNT162b2 vaccination. Pozzetto B; Legros V; Djebali S; Barateau V; Guibert N; Villard M; Peyrot L; Allatif O; Fassier JB; Massardier-Pilonchéry A; Brengel-Pesce K; Yaugel-Novoa M; Denolly S; Boson B; Bourlet T; Bal A; Valette M; Andrieu T; Lina B; ; Cosset FL; Paul S; Defrance T; Marvel J; Walzer T; Trouillet-Assant S Nature; 2021 Dec; 600(7890):701-706. PubMed ID: 34673755 [TBL] [Abstract][Full Text] [Related]
10. Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine. Baldolli A; Fournier A; Verdon R; Michon J Clin Microbiol Infect; 2022 Jun; 28(6):885.e1-885.e5. PubMed ID: 35182759 [TBL] [Abstract][Full Text] [Related]
11. Antibody Response Induced by Two Doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2 in Liver Transplant Recipients. Lim SY; Yoon YI; Kim JY; Tak E; Song GW; Kim SH; Lee SG Immune Netw; 2022 Jun; 22(3):e24. PubMed ID: 35799703 [TBL] [Abstract][Full Text] [Related]
12. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea. Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579 [TBL] [Abstract][Full Text] [Related]
13. Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2. Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson AC; Hellström C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingström J; Hober S; Nilsson P; Åberg M; Thålin C EBioMedicine; 2021 Aug; 70():103523. PubMed ID: 34391088 [TBL] [Abstract][Full Text] [Related]
14. Serum Antibody Response Comparison and Adverse Reaction Analysis in Healthcare Workers Vaccinated with the BNT162b2 or ChAdOx1 COVID-19 Vaccine. Lim SH; Choi SH; Kim B; Kim JY; Ji YS; Kim SH; Kim CK; Kim T; Choo EJ; Moon JE; Yun J; Park SK Vaccines (Basel); 2021 Nov; 9(12):. PubMed ID: 34960125 [TBL] [Abstract][Full Text] [Related]
15. The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2. Ho TC; Chen YA; Chan HP; Chang CC; Chuang KP; Lee CH; Yuan CH; Tyan YC; Yang MH Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696271 [TBL] [Abstract][Full Text] [Related]
19. Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan. Chang JH; Chiou JF; Hung CS; Liu MC; Chang HW; Hong SY; Wang CY; Lin YL; Hsieh YC; Chung CL; Su YS; Hsiao SS; Liu D; Liang JJ; Liao CC; Chang CS; Lai KS; Chuang HC; Chien KL; Wu WC; Lee YG; Lin SE; Shen YK; Hsu CF; Wang JC; Hsiao SH Vaccines (Basel); 2022 Feb; 10(2):. PubMed ID: 35214770 [TBL] [Abstract][Full Text] [Related]
20. Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines. Marking U; Havervall S; Greilert-Norin N; Ng H; Blom K; Nilsson P; Phillipson M; Hober S; Nilsson C; Mangsbo S; Christ W; Klingström J; Gordon M; Åberg M; Thålin C Vaccines (Basel); 2022 Feb; 10(3):. PubMed ID: 35334989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]